Computational Design of Bioactive Epigallocatechin Gallate (EGCG) Analogues Targeting Heme Oxygenase-1 (HO-1) Pathway for Metabolic Regulation

Epigallocatechin-gallate (EGCG) is a flavone-based natural product that has a more significant impact on Diabetes and other cardiometabolic complications.This in silico based computer-aided drug design ensures the drug's Pharmacokinetic parameters and particular compounds towards the precise target.Based on the network data designed, EGCG were docked against PDB: 1N3U, using Dimethyl fumarate as the standard reference.Such desirable quality of modified EGCG will create a spark in the novel drug discovery of a bioenhancer.This slight evidence will support a higher quantum of drug discovery in semisynthetic chemistry toward Metabolic Complications.